HOME >> BIOLOGY >> NEWS
Solution To Bison-Cattle Conflict In Yellowstone

Montana shoots bison that migrate in from Yellowstone National Park because the population carries brucellosis, a disease that can cause abortion in livestock. Because cattle could potentially catch brucellosis by eating infected birth membranes, it would be a good idea to keep them away from the bison population during its birthing period. One pitfall would be if brucellosis-infected bison gave birth over a period longer than the normal two months. However, this is not the case, say Joel Berger of the University of Nevada in Reno and Steven Cain of Grand Teton National Park in Moose, Wyoming.

While millions of bison once lived in North America, by the turn of the century there were fewer than 1000 left. Since then bison have been protected in reserves and ranches and the population has grown to 150,000. But over the last 10 years nearly 3000 bison have been killed as they leave Yellowstone and enter Montana. "This is the greatest public slaughter of bison probably since the heyday some 125 years or more ago," says Berger.

Berger and Cain compared the length of birthing periods in a brucellosis-exposed bison population (in Jackson Hole, Wyoming) with three non-brucellosis-exposed populations (in National Bison Range in Montana and in Wind Cave and Badlands National Parks in South Dakota). The researchers found that the brucellosis-exposed bison did not give birth over a longer period than the three non-brucellosis-exposed populations.

This finding is important because ranchers can predict when it will be safe to put cattle on public lands where bison live. Because 95% of the bison in the Yellowstone area gave birth during May and June, Berger and Cain suggest that ranchers delay putting cattle in the area until July.

Although ranchers are concerned that their cattle might catch brucellosis from bison, this has never happened in the wild. Cattle have caught the disease from bison in experiments--but only at bison densities 1000 times highe
'"/>

Contact: Joel Berger
jberger@wyoming.com
707-864-5909
Society for Conservation Biology
30-Mar-1999


Page: 1 2

Related biology news :

1. 5AM Solutions releases Microarray Enterprise Manage(TM) Software
2. Solution to hospital infections could be in the air
3. Physicists Find Simple Solution To Great-And-Small Mystery
4. BNL Scientists Report On A Natural Cleanup Solution For Polluted Soil & Incinerator Ash
5. Biotech Creates New Solutions And New Problems
6. SFU Researcher Finds Low Cost Solution To High Auto Emissions
7. Virginia Tech Scientist Seek Genetic Solution To Malaria
8. Plant Doctors Find Genetic Solution For Papaya Growers
9. Potential Solutions For Gulf of Mexicos "Dead Zone" Explored
10. Computer Models Find Cost-Effective Solutions For Species Preservation
11. Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Solution Bison Cattle Conflict Yellowstone

(Date:3/11/2015)... , March 11, 2015   The ... its platform to scientifically measure and harness music ... to real-time biometrics and objective measurements of physiology, ... music at scale in large populations. It is ... technologists and clinicians perform rigorous studies and accelerate ...
(Date:3/10/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ... biometric authentication company focused on the growing mobile ... has been named the "Number One Best Tech ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a web ... and lifestyle that have a unique function or design.  ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
(Date:3/30/2015)... , March 30, 2015 CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... Drug Administration (CFDA) has approved the Company,s application to ... clear cell carcinoma (OCCC) patients for its proprietary drug ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... 2015  Naldemedine, an investigational peripherally acting mu-opioid ... Co., Ltd., met its primary and secondary endpoints ... the treatment of opioid-induced constipation (OIC) in adult ... Study results showed that naldemedine (0.2 mg tablet ... of spontaneous bowel movement (SBM) compared with placebo ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: